Literature DB >> 28532551

Strengthening Renal Registries and ESRD Research in Africa.

M Razeen Davids1, Fergus J Caskey2, Taryn Young3, Gillian K Balbir Singh4.   

Abstract

In Africa, the combination of noncommunicable diseases, infectious diseases, exposure to environmental toxins, and acute kidney injury related to trauma and childbirth are driving an epidemic of chronic kidney disease and end-stage renal disease (ESRD). Good registry data can inform the planning of renal services and can be used to argue for better resource allocation, audit the delivery and quality of care, and monitor the impact of interventions. Few African countries have established renal registries and most have failed owing to resource constraints. In this article we briefly review the burden of chronic kidney disease and ESRD in Africa, and then consider the research questions that could be addressed by renal registries. We describe examples of the impact of registry data and summarize the sparse primary literature on country-wide renal replacement therapy in African countries over the past 20 years. Finally, we highlight some initiatives and opportunities for strengthening research on ESRD and renal replacement therapy in Africa. These include the establishment of the African Renal Registry and the availability of new areas for research. We also discuss capacity building, collaboration, open-access publication, and the strengthening of local journals, all measures that may improve the quantity, visibility, and impact of African research outputs.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Africa; Renal registry; open access; research impact; translational research

Mesh:

Year:  2017        PMID: 28532551     DOI: 10.1016/j.semnephrol.2017.02.002

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  2 in total

Review 1.  Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes.

Authors:  Roberto Pecoits-Filho; Ikechi G Okpechi; Jo-Ann Donner; David C H Harris; Harith M Aljubori; Aminu K Bello; Ezequiel Bellorin-Font; Fergus J Caskey; Allan Collins; Alfonso M Cueto-Manzano; John Feehally; Bak Leong Goh; Kitty J Jager; Masaomi Nangaku; Muhibur Rahman; Manisha Sahay; Abdulkarim Saleh; Laura Sola; Rumeyza Turan Kazancioglu; Rachael C Walker; Robert Walker; Qiang Yao; Xueqing Yu; Ming-Hui Zhao; David W Johnson
Journal:  Kidney Int Suppl (2011)       Date:  2020-02-19

2.  Analysis of the vascular access service for patients on haemodialysis in Livingstone Hospital.

Authors:  Ian R Grant; Robert J Freercks; Eduard J Honiball; Bhekifa Dube
Journal:  Cardiovasc J Afr       Date:  2020-11-11       Impact factor: 1.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.